Company news and developments, with original sources and dates.
Updated from source·Oct 20, 2026, 18:05 UTC
On October 6, 2026, per EU-Startups, Paris-based WhiteLab Genomics raised $26 million (€23.2M) in a Series B led by AVP, with new investors Yaday Health and Blast Club, to build AI-designed bio-assets for next-generation genomic medicines.